Prof David Ritchie
Honorary (Professorial Fellow)
Department of Medicine
520 Scholarly works
13 Projects
HIGHLIGHTS
2026
Journal article
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies.
DOI: 10.1016/S2352-3026(26)00005-02026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function
DOI: 10.3389/fimmu.2026.17500932026
Journal article
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
DOI: 10.1080/10428194.2025.25797212021
Research grants (ARC, NHMRC, MRFF)
Diagnosis, Discovery and Novel Phenotype Characterisation Using Multimodal Genomics in Patients With Inherited Bone Marrow Failure and Related Disorders
2021
Research grants (ARC, NHMRC, MRFF)
Repurposing BCL-2 Inhibitors for Immune Manipulation to Improve Outcomes in Allogeneic Stem Cell Transplantation
2018
Research Grant
Inhibiting BCL-2 and Nk Cells Improves Stem Cell Transplant Outcomes in Acute Myeloid Leukaemia
RECENT SCHOLARLY WORKS
2026
Journal article
Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemia
DOI: 10.1080/10428194.2025.25999912026
Journal article
KRAS internal tandem duplications and alternative driver variants in BRAF Val600Glu negative hairy cell leukemia
DOI: 10.1080/10428194.2026.26150552025
Other
Supplementary Data DS1 from A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
DOI: 10.1158/1078-0432.307075642025
Journal article
Establishing the impact of effective donor-specific antibody (DSA) desensitisation in haploidentical and mismatched donor haematopoietic stem cell transplants: An Australian experience
DOI: 10.1182/blood-2025-41992025
Journal article
Utilisation of machine learning algorithms to predict relapse risk following allogeneic stem cell transplantation (alloSCT) for patients with myeloid malignancies
DOI: 10.1182/blood-2025-60812025
Journal article
Immunological responses to blinatumomab treatment in B-acute lymphoblastic leukaemia (B-ALL) patients - australasian leukemia and lymphoma group ALL08 blam study
DOI: 10.1182/blood-2025-3341
RECENT PROJECTS
2026
Research contracts (non-grants)
Developing Translational Insights Into Poor Graft Function Following Allogeneic Stem Cell Transplantation
2025
Research grants (ARC, NHMRC, MRFF)
Personalised Haematopoietic Stem Cells, Moving Transplantation Into the 21st Century